Healthpeak Properties (NYSE:DOC) Price Target Cut to $20.00 by Analysts at Wells Fargo & Company

Healthpeak Properties (NYSE:DOC - Free Report) had its price target trimmed by Wells Fargo & Company from $22.00 to $20.00 in a report issued on Monday morning,Benzinga reports. They currently have an equal weight rating on the real estate investment trust's stock.

DOC has been the subject of a number of other reports. Scotiabank cut their target price on Healthpeak Properties from $23.00 to $21.00 and set a "sector outperform" rating for the company in a research note on Monday, May 12th. Robert W. Baird cut their target price on Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating for the company in a research note on Tuesday, April 29th. Wedbush cut their target price on Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating for the company in a research note on Monday, April 28th. Argus restated a "buy" rating and issued a $25.00 target price on shares of Healthpeak Properties in a research note on Tuesday, April 29th. Finally, Wall Street Zen lowered Healthpeak Properties from a "hold" rating to a "sell" rating in a research note on Thursday, May 1st. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and nine have issued a buy rating to the company's stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $23.27.

Healthpeak Properties Stock Performance

Shares of DOC stock traded up $0.12 during trading hours on Monday, reaching $17.22. 2,857,602 shares of the company's stock were exchanged, compared to its average volume of 5,125,619. The business has a fifty day moving average price of $17.98 and a 200-day moving average price of $19.64. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 0.96. The stock has a market capitalization of $11.96 billion, a P/E ratio of 49.14, a P/E/G ratio of 2.17 and a beta of 1.05. Healthpeak Properties has a fifty-two week low of $16.64 and a fifty-two week high of $23.26.

Healthpeak Properties (NYSE:DOC - Get Free Report) last issued its earnings results on Thursday, April 24th. The real estate investment trust reported $0.46 EPS for the quarter, meeting analysts' consensus estimates of $0.46. The business had revenue of $702.89 million during the quarter, compared to analyst estimates of $690.76 million. Healthpeak Properties had a return on equity of 2.61% and a net margin of 9.00%. Healthpeak Properties's revenue was up 15.9% on a year-over-year basis. During the same period in the prior year, the company posted $0.45 earnings per share. Analysts predict that Healthpeak Properties will post 1.86 EPS for the current fiscal year.

Healthpeak Properties Announces Dividend

The firm also recently announced a dividend, which was paid on Friday, May 30th. Stockholders of record on Tuesday, May 20th were issued a dividend of $0.1017 per share. This represents a dividend yield of 7.05%. The ex-dividend date of this dividend was Monday, May 19th. Healthpeak Properties's payout ratio is presently 305.00%.

Insider Transactions at Healthpeak Properties

In other Healthpeak Properties news, CEO Scott M. Brinker bought 11,337 shares of the firm's stock in a transaction dated Monday, April 28th. The shares were bought at an average price of $17.68 per share, for a total transaction of $200,438.16. Following the completion of the acquisition, the chief executive officer now owns 201,863 shares of the company's stock, valued at approximately $3,568,937.84. This trade represents a 5.95% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director John T. Thomas bought 4,200 shares of the firm's stock in a transaction dated Monday, April 28th. The shares were acquired at an average price of $17.84 per share, for a total transaction of $74,928.00. Following the acquisition, the director now directly owns 813,566 shares of the company's stock, valued at approximately $14,514,017.44. The trade was a 0.52% increase in their position. The disclosure for this purchase can be found here. Over the last quarter, insiders have acquired 29,764 shares of company stock worth $521,909. Insiders own 0.23% of the company's stock.

Institutional Trading of Healthpeak Properties

Several large investors have recently made changes to their positions in the business. Principal Financial Group Inc. boosted its holdings in Healthpeak Properties by 2,113.5% in the fourth quarter. Principal Financial Group Inc. now owns 18,133,812 shares of the real estate investment trust's stock valued at $367,575,000 after acquiring an additional 17,314,572 shares during the last quarter. Norges Bank bought a new position in Healthpeak Properties in the fourth quarter valued at about $166,804,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in Healthpeak Properties by 584.6% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 9,218,848 shares of the real estate investment trust's stock valued at $186,405,000 after acquiring an additional 7,872,150 shares during the last quarter. Nuveen LLC bought a new position in Healthpeak Properties in the first quarter valued at about $124,113,000. Finally, Resolution Capital Ltd bought a new position in Healthpeak Properties in the fourth quarter valued at about $122,795,000. Institutional investors own 93.57% of the company's stock.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.